These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein. Meade RM; Morris KJ; Watt KJC; Williams RJ; Mason JM J Mol Biol; 2020 Dec; 432(24):166706. PubMed ID: 33186583 [TBL] [Abstract][Full Text] [Related]
4. An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein toxic oligomers. Giarola JF; Santos J; Estevez MC; Ventura S; Pallarès I; Lechuga LM Anal Chim Acta; 2024 May; 1304():342559. PubMed ID: 38637056 [TBL] [Abstract][Full Text] [Related]
5. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils. Wood A; Chau E; Yang Y; Kim JR Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941 [TBL] [Abstract][Full Text] [Related]
6. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding. Meade RM; Watt KJC; Williams RJ; Mason JM J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381 [TBL] [Abstract][Full Text] [Related]
7. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils. Yang X; Wang B; Hoop CL; Williams JK; Baum J Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234 [TBL] [Abstract][Full Text] [Related]
8. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide. Mohammadi S; Nikkhah M; Hosseinkhani S Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative. Chau E; Kim H; Shin J; Martinez A; Kim JR Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326 [TBL] [Abstract][Full Text] [Related]
10. Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation. Torpey JH; Meade RM; Mistry R; Mason JM; Madine J Front Neurosci; 2020; 14():561462. PubMed ID: 33177976 [TBL] [Abstract][Full Text] [Related]
11. Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson's Disease. Meena VK; Kumar V; Karalia S; Garima ; Sundd M ACS Chem Neurosci; 2021 Oct; 12(19):3598-3614. PubMed ID: 34506119 [TBL] [Abstract][Full Text] [Related]
13. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons. Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724 [TBL] [Abstract][Full Text] [Related]
14. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization. Candreva J; Chau E; Rice ME; Kim JR Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188 [TBL] [Abstract][Full Text] [Related]
15. Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states. Chau E; Kim JR Biochem Eng J; 2022 Jan; 178():. PubMed ID: 35002469 [TBL] [Abstract][Full Text] [Related]
16. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation. Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733 [TBL] [Abstract][Full Text] [Related]
17. α-synuclein-assisted oligomerization of β-amyloid (1-42). Chau E; Kim JR Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853 [TBL] [Abstract][Full Text] [Related]
18. Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes. Ghio S; Camilleri A; Caruana M; Ruf VC; Schmidt F; Leonov A; Ryazanov S; Griesinger C; Cauchi RJ; Kamp F; Giese A; Vassallo N ACS Chem Neurosci; 2019 Aug; 10(8):3815-3829. PubMed ID: 31356747 [TBL] [Abstract][Full Text] [Related]
19. Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy. Sultana Z; Paleologou KE; Al-Mansoori KM; Ardah MT; Singh N; Usmani S; Jiao H; Martin FL; Bharath MM; Vali S; El-Agnaf OM Neuroscience; 2011 Dec; 199():303-17. PubMed ID: 22056602 [TBL] [Abstract][Full Text] [Related]